Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
ARBs Group:Treatment of ARBs
non-ARBs Group:other treatments
Sponsors
Wuhan Women and Children's Health Care Center
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients meet Diagnosis and treatment of novel coronavirus pneumonia (Seventh Edition); 2. Over 18 years old; 3. Patients with hypertension,diabetes and chronic kidney disease were treated with ARBs or other drugs; 4. Complete data; 5. Agree to participate in the study and cooperate with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Missing or incomplete medical records; 2. 28 day follow-up is incompleted; 3. Co-infection with influenza or other viruses; 4. Discontinuation of antihypertensive or chronic kidney disease treatment is more than 48 hours; 5. ACEIs were used during the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of ARDS;Mortality within 28 days; | — |
Secondary
| Measure | Time frame |
|---|---|
| viral nucleic acid shedding time;Length of hospital stay;Complications;cardiovascular events;CD4+;CD8+;CRP;IL-2;IL-6;PaO2/FiO2; | — |
Countries
China
Contacts
Public ContactZhang Hua-nian
Wuhan Women and Children's Health Care Center
Outcome results
None listed